Simvastatin out-of-pocket cost U.S. 2004-2022

Published by
Matej Mikulic,
Nov 5, 2024

In 2022, the average out-of-pocket cost for simvastatin in the United States dropped to 3.05 U.S. dollars. Simvastatin is primarily used as a lipid-lowering medication. This statistic shows the out-of-pocket cost for simvastatin in the U.S. from 2004 to 2022.

Simvastatin out-of-pocket cost in the U.S. from 2004 to 2022 (in U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2024

Region

United States

Survey time period

2004 to 2022

Supplementary notes

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Drug prices in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Drug prices in the U.S.

Market overview

7

United States vs. abroad

7

Price increase

7

Biosimilars' effects

5

Consumers' views

5

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RomaniaSanofiBiotechnology in SpainBiotech drugsPfizer
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.